company tower banner
Viridis BioPharma Company Logo
Microfoam™ is an innovative antibacterial poly diallyl-dimethylammonium chloride - poly (DADMAC) foam dressing which prevents bacterial penetration and inhibits their growth within wound dressings. It is based on cutting edge patented non-leaching antimicrobial NIMBUS® Technology from Quick-Med Technologies, USA. NIMBUS Technology involves non-toxic, long chain polymers with high charge density that provide superior efficacy via a physical action on microbes..

    Knowde Enhanced TDS

    Features & Benefits

    Product Highlights

    Microfoam™ is effective against broad spectrum of pathogens including Methicillin-resistant Staphylococcus aureus (MRSA) and Vancomycin-resistant Enterococcus (VRE) and prevents development of microbial resistance. With an ability to absorb exudates 20 times of its weight, high porosity allowing evaporation, unique property of preventing cross-contamination, ease application and removal benefits, and longer stability on wound area, Microfoam™ stands out as a highly effective antibacterial foam dressing.